MedPath

Meal Timing, Genetics and Weight Loss

Recruiting
Conditions
Obesity
Registration Number
NCT02829619
Lead Sponsor
Universidad de Murcia
Brief Summary

Meal times differ from culture to culture. These differences may influence energy regulation and, consequently, body weight. Current studies support the notion that not only "what" but also "when" the investigators eat may have a significant role in obesity treatment. Recently, it has been shown that eating the main meal of the day, lunch in Spain, late in the day is predictive of difficulty in weight loss and decreased insulin sensitivity. This project aims to study in a Mediterranean population the potential influence of genetics and food timing on obesity, metabolic syndrome and weight loss.

Detailed Description

Meal times differ from culture to culture. These differences may influence energy regulation and, consequently, body weight. Current studies support the notion that not only "what" but also "when" the investigators eat may have a significant role in obesity treatment. Recently, it has been shown that eating the main meal of the day, lunch in Spain, late in the day is predictive of difficulty in weight loss and decreased insulin sensitivity. Furthermore, it has been shown that eating late at night when plasma melatonin concentrations are elevated, impairs glucose tolerance, particularly in MTNR1B risk allele carriers.

The main objective is to identify the mechanisms underlying the association between the timing of food intake, obesity and metabolic syndrome (MetS) in order to design effective weight loss therapies. The long-term goal is to determine the potential impact of more European, i.e., earlier meal timing on obesity, MetS and weight loss.

The challenge for the society is to develop evidence-based dietary interventions incorporating meal timing and genotype to combat the epidemic of obesity and MetS.

These goals will be achieved through three specific approaches:

* Epidemiological (observational study) (Aim 1): To assess in an obese population (n=5000) who will follow a weight loss program if clock-related (CLOCK, PER2, CRY, etc.) and melatonin-related variants (MTNR1B) interact with the timing of food intake to determine weight loss effectiveness and MetS features.

* Interventional (randomized controlled trials) (Aim 2): To determine the internal mechanisms of energy balance and circadian system implicated in the differential effects of food timing (lunch) on weight loss, MetS alterations and the intestinal microbiota (n=25), and to study the potential interaction between meal timing (dinner) and genetic variants MTNR1B for glucose tolerance in obese women (n=100).

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
5788
Inclusion Criteria
  • Body Mass Index: >25 kg/m2
  • Age: >18 years of age
  • Caucasian
Exclusion Criteria
  • Receiving treatment with thermogenic, lipogenic, or contraceptive drugs
  • Diabetes mellitus, chronic renal failure, hepatic diseases, or cancer diagnosis
  • bulimia diagnosis, prone to binge eating
  • undergoing treatment with anxiolytic or antidepressant drugs

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Total weight lossweekly, during the 28 weeks of treatment

Body weight will be measured in barefoot wearing light clothes, with a digital scale to the nearest 0.1 kg, at the same time each day.

Long term weight loss maintenanceonce at least one year after ending the treatment

Body weight will be measured in barefoot wearing light clothes, with a digital scale to the nearest 0.1 kg.

Secondary Outcome Measures
NameTimeMethod
Macronutrient distribution dietary questionnaireat baseline

by at 24h recall the day before starting the intervention and by a a seven days dietary record during the intervention. Macronutrient (% from total calories of the diet) and (grams) will be calculated

Daily rhythms of activityfrom 3 months to 3 years after weight loss treatment

7 day-record of activity by actiwatch

Glucoseat baseline

Fasting glucose

Barriers to Weight Loss checklistat baseline

A questionnaire will be complete by the participants. The test consisted of 29 questions classified into seven sections: meal recording; weight control and weekly interviews; eating habits; portion size; food and drink choice; way of eating; and other obstacles to weight loss. There are were three possible responses (never 0, sometimes 1, very often 2) to those questions that represented barriers to losing weight, such as ''Have you lost your motivation?'' or ''Do you have binges?'' Questions that represented aids to weight loss, such as ''Do you accurately measure your portions?'' or ''Is absolutely everything written down?'' applied the same score (0 to 2) but with negative signs. A final ''Barriers to Weight Loss'' score is calculated by adding every answer's score for each patient.

Food timingat baseline

Timing of breakfast, lunch and dinner

Food habits questionnaireat baseline

Variety of food groups is assessed by at 24h recall the day before starting the intervention and by a a seven days dietary record during the intervention. The number of different food items per day will be counted to assess variety of food

Physical activity questionnaireat baseline

by the IPAQ (international Physical Activity Questionnaire)

Mediterranean Diet Score questionnaireat baseline

By the questionnaire developed by Antonia Trichopoulou, M.D., Tina Costacou, Ph.D., Christina Bamia, Ph.D., and Dimitrios Trichopoulos, M.D.

N Engl J Med 2003; 348:2599-2608June 26, 2003DOI: 10.1056/NEJMoa025039

Daily rhythms of autonomus system by ambulatory electrocardiographyfrom 3 months to 3 years after weight loss treatment

7 days of ambulatory electrocardiography

Insulinat baseline

Fasting insulin

Siesta timing questionnaireat baseline

Habitual siesta timing is estimated using a self-reported questionnaire.

Individual chronotype questionnaireat baseline

With the Morning and Eveningness Questionnaire (MEQ)

Total energy intake dietary questionnaireat baseline

by at 24h recall the day before starting the intervention and by a a seven days dietary record during the intervention. Daily energy intake will be calculated

Emotional eating questionnaireat baseline

The EEQ (Emotional eating Questionnaire) will be used extent emotions affect eating behaviour. . All the questions had four possible replies: 1) Never, 2) Sometimes; 3) Generally and 4) Always. Each reply was given a score of 1 to 4, the lower the score, the healthier the behaviour. For the clinical practice subjects are classified in four groups attending to the score obtained. Score between 0-5: non-emotional eater. Score between 6-10: low emotional eater. Score between 11-20: emotional eater. Score between 21-30: very emotional eater.

Sleep timingat baseline

Habitual sleep timing is estimated using a self-reported questionnaire.

Glycemic Index questionnaireat baseline

by at 24h recall the day before starting the intervention and by a a seven days dietary record during the intervention. The glycemic index will be calculated by using different composition tables

Glucose tolerancefrom 1 year to 3 years after weight loss treatment

either by meal test or by glucose tolerance test

Daily rhythms of wrist temperaturefrom 3 months to 3 years after weight loss treatment

7 day-record of wrist temperature by wrist temperature sensors.

Trial Locations

Locations (1)

University of Murcia

🇪🇸

Murcia, Spain

© Copyright 2025. All Rights Reserved by MedPath